Serum Institute of India has received Indian regulatory approval to resume local clinical trials of AstraZeneca's potential COVID-19 vaccine, a source familiar with the matter said on Wednesday.
FILE PHOTO: A test tube labelled with the Vaccine is seen in front of Covid-19 and stock graph logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
MUMBAI/BENGALURU - Serum Institute of India has received Indian regulatory approval to resume local clinical trials of AstraZeneca’s potential COVID-19 vaccine, a source familiar with the matter said on Wednesday.AstraZeneca has resumed British clinical trials of the vaccine - one of the most advanced in development for COVID-19 - after they were paused earlier this month following a serious side effect in a trial participant.The trial remains on hold in the United States, the U.S.
Serum, the world’s biggest vaccine manufacturer, did not immediately respond to Reuters’ requests for comment. The DCGI did not return an email seeking comment. Reporting by Euan Rocha in Mumbai, Sachin Ravikumar and Anuron Kumar Mitra in Bengaluru; Editing by Anil D’Silva
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
AstraZeneca COVID-19 vaccine trials resume in BrazilClinical trials for the coronavirus vaccine being developed by AstraZeneca PLC and Oxford University resumed in Brazil on Monday after the country's health regulator got confirmation over the weekend that its British equivalent MHRA had approved the restart, a company representative...
Weiterlesen »
Exclusive: AstraZeneca COVID-19 vaccine trial in U.S. on hold until at least midweek - sourcesAstraZeneca's COVID-19 vaccine trial remains on hold in the United States pending a U.S. investigation into a serious side effect in Britain even as other trials of the vaccine resume, sources familiar with the details told Reuters.
Weiterlesen »
Some volunteers quit J&J COVID-19 trial in Spain after AstraZeneca scare: investigatorSome volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday.
Weiterlesen »
Some volunteers quit J&J COVID-19 trial in Spain after AstraZeneca scare, investigator saysSome volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday.
Weiterlesen »
WHO praises AstraZeneca COVID-19 vaccine trial pauseA World Health Organization official on Tuesday said that the decision by AstraZeneca to pause global trials of its experimental coronavirus vaccine after an unexplained illness showed the firm was prioritising safety.
Weiterlesen »
AstraZeneca's COVID-19 vaccine trial in the U.S. remains halted: reportU.S. trials of AstraZeneca Plc.'s undefined and Oxford University COVID-19 vaccine candidate will be on hold until at least midweek, pending a Federal Drug...
Weiterlesen »